Removal of thymic-derived lymphocytes during pheresis procedures.
D000328:Adult; D001782:Blood Donors; D002498:Centrifugation; D003907:Dexamethasone / Q000494:pharmacology; D005260:Female; D006098:Granulocytes / Q000637:transplantation; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000494:pharmacology; D007937:Leukapheresis / Q000009:adverse effects*; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008231:Lymphopenia / Q000209:etiology*; D008297:Male; D017713:Platelet Transfusion; D011241:Prednisone / Q000494:pharmacology; D013601:T-Lymphocytes / Q000502:physiology*; D014462:Ultrafiltration
D006895:Hydroxyethyl Starch Derivatives; D003907:Dexamethasone; D011241:Prednisone